COX-2 Cmte. Conflict Of Interest Disclosure Is Subject Of Grassley Inquiry
This article was originally published in The Pink Sheet Daily
Executive Summary
The Senate Finance Committee chairman asks FDA Acting Commissioner Crawford to respond to questions about "the appearance" of a conflict of interest for many of the advisory committee members due to alleged ties with industry. Grassley asks for responses from the agency by March 11.